Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

DXCM - DEXCOM INC

IEX Last Trade
80.18
5.290   6.598%

Share volume: 0
Last Updated: Tue 24 Dec 2024 06:01:07 PM CET
Surgical and Medical Instrument Manufacturing : 50.37%

PREVIOUS CLOSE
CHG
CHG%
$74.89
5.29
7.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
60%
Profitability 85%
Dept financing 25%
Liquidity 46%
Performance 49%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0.25%
1 Month
3.10%
3 Months
20.25%
6 Months
-27.26%
1 Year
-34.32%
2 Year
-28.00%
Key data
Stock price
$80.18
P/E Ratio 
41.67
DAY RANGE
$74.89 - $80.54
EPS 
$1.58
52 WEEK RANGE
$67.15 - $142.00
52 WEEK CHANGE
-$35.15
MARKET CAP 
27.786 B
YIELD 
N/A
SHARES OUTSTANDING 
400.727 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/24/2024
BETA 
0.48
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,216,130
AVERAGE 30 VOLUME 
$3,529,754
Company detail
CEO: Kevin R. Sayer
Region: US
Website: dexcom.com
Employees: 7,600
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

DexCom, Inc. focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system.

Recent news